AzTrials
AzTrials

Acute Mechanical Ventilatory FailureRescueHFONCT02752438

Rescue High Frequency Oscillatory Ventilation in Newborns Who Do Not Respond to Conventional Ventilation

An observational study of Acute Mechanical Ventilatory Failure, run by Ankara University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Although High Frequency Oscillatory Ventilation (HFOV) has been used in case of unresponsive to conventional mechanical ventilation both in children and newborns, there is no data on its success and the factors that affect its success in the literature. Read more about this study

Who is it for?
Ages 1 day to 28 days
Conditions the study is for
Acute Mechanical Ventilatory Failure
What is being tested?
HFOV
Type of treatment
Medical device
How many people
400 participants
Where
1 siteTurkey (Türkiye)
Study dates
May 2016to Jul 2017
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Study population: Newborns with respiratory insufficiency in spite of conventional mechanical ventilation are candidates for the study. When the patient is switched to HFOV for rescue respiratory support, he/she will be followed and registered to online registry system.

Who may be able to join

  • patients switched to HFOV in case of unresponse to conventional ventilation
  • stay on HFOV for at least 4 h

Who cannot join

  • any congenital anomaly
  • HFOV duration less then 4 h

Trial locations and contacts

1 site in 1 country.

Emel Okulu, Attending contact

5054812151

emelokulu@gmail.com

Omer Erdeve contact

5054812151

Turkey (Türkiye)1 site, 1 recruiting
  • Ankara University Children's Hospital

    Ankara, Ankara, 06100

    Omer Erdeve, Professor, +905054812151, omererdeve@yahoo.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Although High Frequency Oscillatory Ventilation (HFOV) has been used in case of unresponsive to conventional mechanical ventilation both in children and newborns, there is no data on its success and the factors that affect its success in the literature.

Read the detailed description

Although High Frequency Oscillatory Ventilation (HFOV) has been used in case of unresponsive to conventional mechanical ventilation both in children and newborns, there is no data on its success and the factors that affect its success in the literature.

The aim of the study is to define the factors that affect the success of HFOV in newborns who do not respond to conventional mechanical ventilation through an online registry among neonatal intensive care units in Turkey.

Being tested
HFOV
Keywords
high frequency oscillatory ventilation, rescue, newborn

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HFOVDevice

    HFOV is a kind of respiratory support with a rate higher than physiological but with lesser volume.

Study groups in NCT02752438
Study groupRoleWhat they receive
SurvivedPatients who are treated with HFOV at least for 4 h in case of unresponse to conventional ventilation and survived.
Receives: Device: HFOV
DeathPatients who are treated with HFOV at least for 4 h in case of unresponse to conventional ventilation but died.
Receives: Device: HFOV

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival

    Measured: 3 months

Secondary outcomes (2)
  1. Cut-off gestational age for survival

    Measured: 3 months

  2. Cut-off birthweight for survival

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2016 (estimated)
  2. Study startMay 2016
  3. Primary completionMay 2017 (estimated)
  4. Study completionJul 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
400 participants (estimated)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT02752438
Sponsor's protocol ID
RescueHFO
Acronym
RescueHFO
Status last verified
Sep 2016
First submitted
23 Apr 2016
Last updated
13 Sep 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No: No individual data will be shared.

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Mechanical Ventilatory Failure, run by Ankara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Emel Okulu, Attending (5054812151, emelokulu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in